AUG 19, 2026 · INTERVENTIONAL STUDY
GLP-1 RA on Alcohol Consumption, Metabolism and Liver Parameters in Patients With Obesity and Fatty Liver Disease
ClinicalTrials.gov
This is a registered interventional study not yet recruiting with no posted results; it represents planned work to test whether semaglutide plus counselling improves alcohol abstinence versus counselling alone in patients with obesity and fatty liver disease.
Reported
Planned enrollment64
Study duration per patient16 weeks
Primary outcome measureProportion of patients achieving total alco…